273 related articles for article (PubMed ID: 15781667)
1. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
[TBL] [Abstract][Full Text] [Related]
2. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
Woodson K; Tangrea JA; Lehman TA; Modali R; Taylor KM; Snyder K; Taylor PR; Virtamo J; Albanes D
Cancer Causes Control; 2003 Aug; 14(6):513-8. PubMed ID: 12948282
[TBL] [Abstract][Full Text] [Related]
3. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
4. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.
Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Wu K; Erdman JW; Giovannucci E
Carcinogenesis; 2008 Dec; 29(12):2335-40. PubMed ID: 18784358
[TBL] [Abstract][Full Text] [Related]
5. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
6. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
Nordström T; Van Blarigan EL; Ngo V; Roy R; Weinberg V; Song X; Simko J; Carroll PR; Chan JM; Paris PL
Prostate; 2016 Mar; 76(4):339-48. PubMed ID: 26585352
[TBL] [Abstract][Full Text] [Related]
7. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer.
Ambrosone CB; Freudenheim JL; Thompson PA; Bowman E; Vena JE; Marshall JR; Graham S; Laughlin R; Nemoto T; Shields PG
Cancer Res; 1999 Feb; 59(3):602-6. PubMed ID: 9973207
[TBL] [Abstract][Full Text] [Related]
8. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
9. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Chan JM; Oh WK; Xie W; Regan MM; Stampfer MJ; King IB; Abe M; Kantoff PW
J Clin Oncol; 2009 Aug; 27(22):3577-83. PubMed ID: 19528373
[TBL] [Abstract][Full Text] [Related]
10. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort.
Choi JY; Neuhouser ML; Barnett MJ; Hong CC; Kristal AR; Thornquist MD; King IB; Goodman GE; Ambrosone CB
Carcinogenesis; 2008 May; 29(5):964-70. PubMed ID: 18296681
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer.
Tong SY; Lee JM; Song ES; Lee KB; Kim MK; Lee JK; Son SK; Lee JP; Kim JH; Kwon YI
Gynecol Oncol; 2009 Nov; 115(2):272-6. PubMed ID: 19706356
[TBL] [Abstract][Full Text] [Related]
12. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.
Goodman M; Bostick RM; Ward KC; Terry PD; van Gils CH; Taylor JA; Mandel JS
Nutr Cancer; 2006; 55(1):13-20. PubMed ID: 16965236
[TBL] [Abstract][Full Text] [Related]
13. Association of MnSOD AA Genotype with the Progression of Prostate Cancer.
Iguchi T; Wang CY; Delongchamps NB; Kato M; Tamada S; Yamasaki T; de la Roza G; Nakatani T; Haas GP
PLoS One; 2015; 10(7):e0131325. PubMed ID: 26147925
[TBL] [Abstract][Full Text] [Related]
14. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
[TBL] [Abstract][Full Text] [Related]
15. Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study.
Ergen HA; Narter F; Timirci O; Isbir T
Anticancer Res; 2007; 27(2):1227-30. PubMed ID: 17465268
[TBL] [Abstract][Full Text] [Related]
16. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
17. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
18. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma carotenoids and prostate cancer.
Chang S; Erdman JW; Clinton SK; Vadiveloo M; Strom SS; Yamamura Y; Duphorne CM; Spitz MR; Amos CI; Contois JH; Gu X; Babaian RJ; Scardino PT; Hursting SD
Nutr Cancer; 2005; 53(2):127-34. PubMed ID: 16573373
[TBL] [Abstract][Full Text] [Related]
20. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.
Tamimi RM; Hankinson SE; Spiegelman D; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):989-96. PubMed ID: 15184255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
